Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 150 for vascular surgery

Edit search filters
  1. A Study to Evaluate a Novel Technique to Diagnose Carotid Artery Stenosis

    Rochester, MN

  2. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol

    Rochester, MN

  3. Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease

    Rochester, MN

  4. Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  5. Preventing Lymphedema in Axillary Lymph Node Dissection

    Jacksonville, FL, Rochester, MN

  6. Apixaban in Preventing Secondary Cancer Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Eau Claire, WI, Rochester, MN

  7. The Ventilatory Response to Activation of the Locomotor Afferents in Normoxic and Hypoxic Conditions

    Rochester, MN

  8. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis

    Rochester, MN

  9. A Study to Evaluate the Safety and Effectiveness of Antithrombotics to Treat Hospitalized COVID-19 Patients

    Scottsdale/Phoenix, AZ

  10. ABSORB III Randomized Controlled Trial (RCT)

    Rochester, MN

.

Mayo Clinic Footer